Abstract
Objectives
To evaluate the Quality of life (QoL) and the factors affecting it in transfusion-dependent thalassemic children.
Methods
Current study was conducted at Department of Pediatrics, Dr. SNMC, Jodhpur. Ninety-three transfusion-dependent thalassemic children aged between 8 and 18 y were enrolled. Quality of life was assessed using Pediatric Quality of Life (PedsQL) measurement model in thalassemic children.
Results
Mean age of children was 11.8 ± 3.2 y. Lowest mean score was observed in School functioning (57.4) while in Physical functioning, Emotional functioning and Social functioning it was 73.9, 82.2 and 83.49 respectively. Mean PedsQL score was higher in 8-12 y age group as compared to 13-18 y (p = 0.024). PedsQL score was higher in children who required transfusion once in a month (p = 0.028) and children on combined chelation therapy as compared to children who were on injectable chelator (p = 0.039). Health Related QoL was not affected with gender, education status, family history of thalassemia, ferritin level, splenectomy or consanguinity.
Conclusions
Factors related with low QoL in current study were higher age, increased transfusion frequency and injectable mode of chelation. In order to improve the QoL in thalassemic children appropriate programmes and interventions should be started targeting above domains.
Similar content being viewed by others
References
Kaheni S, Yaghobian M, Sharefzadah GH, Vahidi A, Ghorbani H, Abderahemi A. Quality of life in children with Β-thalassemia major at center for special diseases. Iran J Pediatr Hematol Oncol. 2013;3:108–13.
Colah RB, Gorakshakar AC, Nadkarni AH. Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India. Indian J Med Res. 2011;134:552–60.
Eiser C. Psychological effects of chronic disease. J Child Psychol Psychiatry. 1990;31:85–98.
Esmaeilzadeh F, Azarkeivan A, Emamgholipour S, et al. Economic burden of thalassemia major in Iran, 2015. J Res Health Sci. 2016;16:111–5.
Ygge BM, Arnett JE. A study of parental involvement in pediatric hospital care: implications for clinical practice. J Paediatr Nurs. 2004;19:217–23.
Varni JW, Seid M, Rode CA. The PedsQL™: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126–39.
Soni S, Thawani R, Idhate T, Kalra M, Mahajan A. Health related quality of life in patients with transfusion- dependent thalassemia. Indian Pediatr. 2016;53:741–2.
Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007;74:727–30.
Gupta M, Jindal R. Quality of life in patients with thalassemia major. Int J Sci Res. 2016;5:41–2.
Sharma S, Seth B, Jawade P, Ingale M, Setia MS. Quality of life in children with thalassemia and their caregivers in India. Indian J Pediatr. 2017;84:188–94.
Akbar Bagloo M, Habibpour Z. Relationship between mental health and use of agreeable methods in the parents with thalassemia and hemophilia. UNMF. 2010;8:191–6.
Gharaibeh HF, Gharaibeh MK. Factors influencing health-related quality of life of thalassaemic Jordanian children. Child Care Health Dev. 2012;38:211–8.
Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassaemia. Health Qual Life Outcomes. 2006;4:39.
Baraz S, Miladinia M, Nouri EM. A comparison of quality of life between adolescences with beta thalassemia major and their healthy peers. Int J Pediatr. 2016;4:1195–204.
Ayoub MD, Radi SA, Azab AM, Abulaban A, Balkhoyor AH, Bedair SW. Quality of life among children with beta-thalassemia major treated in western Saudi Arabia. Saudi Med J. 2013;34:1281–6.
Pakbaz Z, Treadwell M, Yamshita R, et al. Quality of life in patients with thalasssemia intermediate compared to thalassemia major. Ann N Y Acad Sci. 2005;1054:457–61.
Riaz H, Riaz T, Khan MU, et al. Serum ferritin levels, socio-demographic factors and desferrioxamine therapy in multi-transfused thalassemia major patients at a government tertiary care hospital of Karachi, Pakistan. BMC Res Notes. 2011;4:287.
Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord. 2010;10:1.
Khurana A, Katyal S, Marwaha RK. Psychosocial burden in thalaasemia. Indian J Pediatr. 2006;73:877–80.
Cheuk DK, Mok AS, Lee AC. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319–27.
Caocci G, Efficace F, Ciotti F, et al. Health related quality of life in middle eastern children with beta-thalassemia. BMC Hematol. 2012;12:6.
Mikelli A, Tsiantis J. Brief report: depressive symptoms and quality of life in adolescents with b-thalassaemia. J Adolesc. 2004;27:213–6.
Dahlui M, Hishamshah MI, Rahman AJA, Aljunid SM. Quality of life in transfusion dependent thalassaemia patients on desferrioxamine treatment. Singap Med J. 2009;50:794–9.
Naderi M, Hormozi MR, Ashrafi M, Emamdadi A. Evaluation of mental health and related factors among patients with beta-thalassemia major in south east of Iran. Iran J Psychiatry. 2012;7:47–51.
Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann N Y Acad Sci. 2005;1054:273–82.
Cappellini MD, Cohen A, Piga A, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107:3455–62.
Contributions
KC: Enrolled the patients and prepared the manuscript; VK: Designed the study and analysed and prepared the manuscript; PS: Designed, planned and analysed and prepared the manuscript; BD: Patient enrollment, data collection and analysis; SK: Data analysis, preparation of manuscript and reviewing the manuscript. PS will act as guarantor for this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Rights and permissions
About this article
Cite this article
Chordiya, K., Katewa, V., Sharma, P. et al. Quality of Life (QoL) and the Factors Affecting it in Transfusion-dependent Thalassemic Children. Indian J Pediatr 85, 978–983 (2018). https://doi.org/10.1007/s12098-018-2697-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-018-2697-x